RAIN
Rain Oncology Inc. Common Stock
RAIN
RAIN
Delisted
RAIN was delisted on the 25th of January, 2024.
62 hedge funds and large institutions have $20M invested in Rain Oncology Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+3
Holders Change %
+5.08%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
29
Increased
21
Reduced
7
Closed
26
Calls
$56K
Puts
$91K
Net Calls
-$35K
Net Calls Change
+$475K
Top Buyers
1 |
TCM
Tang Capital Management
San Diego,
California
|
+$4.49M |
2 |
BlackRock
New York
|
+$1.13M |
3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$787K |
4 |
Millennium Management
New York
|
+$668K |
5 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$417K |
Top Sellers
1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$26M |
2 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
-$18.6M |
3 |
PA
Perceptive Advisors
New York
|
-$14.4M |
4 |
Janus Henderson Group
London,
United Kingdom
|
-$11.7M |
5 |
GC
GMT Capital
Atlanta,
Georgia
|
-$7.21M |